263 related articles for article (PubMed ID: 19503830)
1. The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development.
Lindvall C; Zylstra CR; Evans N; West RA; Dykema K; Furge KA; Williams BO
PLoS One; 2009 Jun; 4(6):e5813. PubMed ID: 19503830
[TBL] [Abstract][Full Text] [Related]
2. Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.
Goel S; Chin EN; Fakhraldeen SA; Berry SM; Beebe DJ; Alexander CM
J Biol Chem; 2012 May; 287(20):16454-66. PubMed ID: 22433869
[TBL] [Abstract][Full Text] [Related]
3. The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.
Badders NM; Goel S; Clark RJ; Klos KS; Kim S; Bafico A; Lindvall C; Williams BO; Alexander CM
PLoS One; 2009 Aug; 4(8):e6594. PubMed ID: 19672307
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
5. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis.
Lindvall C; Evans NC; Zylstra CR; Li Y; Alexander CM; Williams BO
J Biol Chem; 2006 Nov; 281(46):35081-7. PubMed ID: 16973609
[TBL] [Abstract][Full Text] [Related]
6. Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.
Ahn Y; Sims C; Logue JM; Weatherbee SD; Krumlauf R
Development; 2013 Feb; 140(3):583-93. PubMed ID: 23293290
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.
Ettenberg SA; Charlat O; Daley MP; Liu S; Vincent KJ; Stuart DD; Schuller AG; Yuan J; Ospina B; Green J; Yu Q; Walsh R; Li S; Schmitz R; Heine H; Bilic S; Ostrom L; Mosher R; Hartlepp KF; Zhu Z; Fawell S; Yao YM; Stover D; Finan PM; Porter JA; Sellers WR; Klagge IM; Cong F
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15473-8. PubMed ID: 20713706
[TBL] [Abstract][Full Text] [Related]
8. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
[TBL] [Abstract][Full Text] [Related]
9. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
Lu W; Liu CC; Thottassery JV; Bu G; Li Y
Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
[TBL] [Abstract][Full Text] [Related]
10. Functional interactions between the LRP6 WNT co-receptor and folate supplementation.
Gray JD; Nakouzi G; Slowinska-Castaldo B; Dazard JE; Rao JS; Nadeau JH; Ross ME
Hum Mol Genet; 2010 Dec; 19(23):4560-72. PubMed ID: 20843827
[TBL] [Abstract][Full Text] [Related]
11. Lrp5 and Lrp6 play compensatory roles in mouse intestinal development.
Zhong Z; Baker JJ; Zylstra-Diegel CR; Williams BO
J Cell Biochem; 2012 Jan; 113(1):31-8. PubMed ID: 21866564
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of LRP6 function by casein kinase I epsilon phosphorylation.
Swiatek W; Kang H; Garcia BA; Shabanowitz J; Coombs GS; Hunt DF; Virshup DM
J Biol Chem; 2006 May; 281(18):12233-41. PubMed ID: 16513652
[TBL] [Abstract][Full Text] [Related]
13. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
Mi K; Johnson GV
J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991
[TBL] [Abstract][Full Text] [Related]
14. The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo.
Bryja V; Andersson ER; Schambony A; Esner M; Bryjová L; Biris KK; Hall AC; Kraft B; Cajanek L; Yamaguchi TP; Buckingham M; Arenas E
Mol Biol Cell; 2009 Feb; 20(3):924-36. PubMed ID: 19056682
[TBL] [Abstract][Full Text] [Related]
15. Wnt signal amplification via activity, cooperativity, and regulation of multiple intracellular PPPSP motifs in the Wnt co-receptor LRP6.
MacDonald BT; Yokota C; Tamai K; Zeng X; He X
J Biol Chem; 2008 Jun; 283(23):16115-23. PubMed ID: 18362152
[TBL] [Abstract][Full Text] [Related]
16. Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition.
Riddle RC; Diegel CR; Leslie JM; Van Koevering KK; Faugere MC; Clemens TL; Williams BO
PLoS One; 2013; 8(5):e63323. PubMed ID: 23675479
[TBL] [Abstract][Full Text] [Related]
17. Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.
Wang Z; Shu W; Lu MM; Morrisey EE
Mol Cell Biol; 2005 Jun; 25(12):5022-30. PubMed ID: 15923619
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6.
Bourhis E; Tam C; Franke Y; Bazan JF; Ernst J; Hwang J; Costa M; Cochran AG; Hannoush RN
J Biol Chem; 2010 Mar; 285(12):9172-9. PubMed ID: 20093360
[TBL] [Abstract][Full Text] [Related]
20. Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins.
Brennan K; Gonzalez-Sancho JM; Castelo-Soccio LA; Howe LR; Brown AM
Oncogene; 2004 Jun; 23(28):4873-84. PubMed ID: 15064719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
